Baru almond improves lipid profile in mildly hypercholesterolemic subjects: A randomized, controlled, crossover study

Abstract Backgroud and aim The usual consumption of nuts reduces cardiovascular diseases (CVD) risk by improving serum lipids and oxidation status. Baru almonds ( Dipteryxalata Vog.), a native species of Brazilian Savannah, have considerable contents of monounsaturated fatty acids (MUFA), dietary fi...

Full description

Saved in:
Bibliographic Details
Published in:Nutrition, metabolism, and cardiovascular diseases metabolism, and cardiovascular diseases, 2014-12, Vol.24 (12), p.1330-1336
Main Authors: Bento, A.P.N, Cominetti, C, Simões Filho, A, Naves, M.M.V
Format: Article
Language:English
Subjects:
Adult
Body Composition
Body Mass Index
Cardiovascular
Cardiovascular diseases
Cross-Over Studies
Diet
Dyslipidemias
Female
Health Status
Humans
Hypercholesterolemia - blood
Hypercholesterolemia - diet therapy
Lipids - blood
Male
Middle Aged
Nuts
Oxidation-Reduction
Oxidative stress
Prunus - chemistry
Thiobarbituric Acid Reactive Substances - metabolism
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Backgroud and aim The usual consumption of nuts reduces cardiovascular diseases (CVD) risk by improving serum lipids and oxidation status. Baru almonds ( Dipteryxalata Vog.), a native species of Brazilian Savannah, have considerable contents of monounsaturated fatty acids (MUFA), dietary fiber, vitamin E and zinc, which could exert positive effects in serum lipids and markers of oxidation. However, there is no study about the effect of their consumption on human health. Thus, the aim of this study was to evaluate the effect of baru almonds supplementation on lipid profile and oxidation of mildly hypercholesterolemic subjects. Methods and Results A randomized, crossover, placebo controlled study was performed with 20 mildly hypercholesterolemic subjects (total cholesterol (TC) mean ±SEM = 5.8 ± 0.2 mmol/L). The assay had 2 periods of 6 weeks each and a 4-week washout period between the treatments. Subjects were randomly allocated in alternated periods receiving the following treatments per period: supplementation with 20 g/day of baru almonds or placebo (1 corn starch capsule/day). Compared to placebo, supplementation of baru almonds reduced TC (−8.1 ± 2.4%, P  = 0.007), low-density lipoprotein cholesterol (LDL-c) (−9.4 ± 2.4%, P  = 0.006) and non-high-density lipoprotein cholesterol (non-HDL-c) (−8.1 ± 3.0%, P  = 0.013). There were no significant changes on the oxidation biomarkers evaluated. Conclusion Dietary supplementation of mildly hypercholesterolemic subjects with baru almonds improved serum lipid parameters, so that this food might be included in diets for reducing the CVD risk. Clinical Trial registry Brazilian Registry of Clinical Trials (ReBEC) (website: http://www.ensaiosclinicos.gov.br ). Register number: RBR-4zdy9p.
ISSN:0939-4753
1590-3729
DOI:10.1016/j.numecd.2014.07.002